Emerging And Re Emerging Infectious Diseases Grades 9 12 Nih Curriculum Supplement Series

This curriculum supplement guide brings the latest medical discoveries to classrooms. This module focuses on the objectives of introducing students to major concepts related to emerging and re-emerging infectious diseases, and developing an understanding of the relationship between biomedical research and personal and public health. This module includes five major sections: (1) "Understanding Emerging and Re-Emerging Infectious Diseases"; (2) "Implementing Module"; (3) "Student Activities"; (4) Additional Resources for Teachers; and (5) a glossary and references section. (Contains 27 references.) (YDS)

Contains a supplemental science program that introduces students to major concepts related to infectious diseases and their control as well as exploring the relationship between biomedical research and improvements in personal and public health.

Gold Winner 2012 Foreword Reviews Book of The Year, Health Category The U.S. Centers for Disease Control and Prevention estimates 1.7 million people developed healthcare acquired infections in 2010. Since most people spend only a small part of their lives in healthcare facilities, this guidebook also tells readers how to avoid picking up serious infections in day care centers, schools, business offices, and other common locations. Unlike other books, which focus on how to change the hospital systems, The Patient Survival Guide focuses on empowering you with the knowledge and techniques to ensure a safer healthcare experience. The Patient Survival Guide: Inspires you to be a your own advocate Describes in vivid detail how your preparation and informed vigilance can significantly reduce the chances of harm and death to your loved one in a hospital Provides specific, practical, and outside-the-box strategies for anticipating and preventing errors, with chapters devoted to each of the most common mistakes and mishaps Provides checklists for patients to use upon admission to healthcare facilities

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

The Transformational Medical Technologies (TMT) has been a unique component of the U.S. Department of Defense (DoD) medical biodefense efforts since 2006. Its mission is to advance countermeasure research and development in support of the broader goal of the DoD to protect warfighters from emerging infectious diseases and future genetically engineered biological weapons. The TMT, using advanced science and technology approaches, focused on the development of roadspectrum countermeasures that target common host and pathogen pathways or enhance the host's immune response. Many of these pathogens are lethal or cause such debilitating diseases in humans that it is ethically inappropriate to test the efficacy of these countermeasures in human volunteers. In lieu of human participants, these products may be tested in animals and approved for human use under the provisions of the Food and Drug Administration (FDA)'s 2002 Animal Rule. The reliance on animal models for the development and licensure of medical countermeasures against biothreats is challenging for a number of reasons. The ad hoc Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents prepared a consensus report that would address the challenges stemming from developing and testing medical countermeasures against biothreat agents in animal models. Animal Models for Assessing Countermeasures to Bioterrorism Agents evaluates how well the existing TMT-employed or candidate animal models reflect the pathophysiology, clinical picture, and treatment of human disease as related to the agents of interest. The report addresses the process and/or feasibility of developing new animal models for critical biodefense research, placing emphasis on the need for a robust and expeditious validation process in terms of the FDA's Animal Rule. The report also evaluates alternatives to the use of animal models based on the premise of the Three Rs.